Response to Comment on: Kim et al. Prospective Study of Serum Adiponectin and Incident Metabolic Syndrome: The ARIRANG Study. Diabetes Care 2013;36:1547–1553

Схожие документы

• Comment on: Kim et al. Prospective Study of Serum Adiponectin and Incident Metabolic Syndrome: The ARIRANG Study. Diabetes Care 2013;36:1547–1553
  по: Kawada, Tomoyuki
  Опубликовано: (2013)
• Prospective Study of Serum Adiponectin and Incident Metabolic Syndrome: The ARIRANG study
  по: Kim, Jang-Young, et al.
  Опубликовано: (2013)
• Comment on: Bernstein. Reducing Foot Wounds in Diabetes. Diabetes Care 2013;36:e48
  по: Morbach, Stephan, et al.
  Опубликовано: (2013)
• Comment on: Tsiakou et al. Arterial Stiffness Is Inversely Related to Plasma Adiponectin Levels in Young Normotensive Patients With Type 1 Diabetes. Diabetes Care 2013;36:734–736
  по: Hamasaki, Hidetaka, et al.
  Опубликовано: (2013)
• Comment on Knowler et al. Preventing Diabetes in American Indian Communities. Diabetes Care 2013;36:1820–1822
  по: Jiang, Luohua, et al.
  Опубликовано: (2014)